Recent Advances in the Treatment of Sickle Cell Disease
Sickle cell anemia (SCA) was first described in the Western literature more than 100 years ago. Elucidation of its molecular basis prompted numerous biochemical and genetic studies that have contributed to a better understanding of its pathophysiology. Unfortunately, the translation of such knowledg...
Main Authors: | Gabriel Salinas Cisneros, Swee L. Thein |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2020.00435/full |
Similar Items
-
Dental considerations in the management of children suffering from sickle cell disease: A case report
by: Ramakrishna Y
Published: (2007-09-01) -
Minimal doses of hydroxyurea for sickle cell disease
by: C.S.P. Lima, et al.
Published: (1997-08-01) -
The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease
by: F. Moreira Neto, et al.
Published: (2006-10-01) -
Sickle cell disease presenting in the third trimester of pregnancy: Delayed detection heralding a public health problem?
by: Ankita Sharma, et al.
Published: (2020-01-01) -
The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)
by: Ana C. Silva-Pinto, et al.
Published: (2019-01-01)